These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


536 related items for PubMed ID: 22017430

  • 1. Non-canonical NF-κB signaling activation and regulation: principles and perspectives.
    Razani B, Reichardt AD, Cheng G.
    Immunol Rev; 2011 Nov; 244(1):44-54. PubMed ID: 22017430
    [Abstract] [Full Text] [Related]

  • 2. TNFα induced noncanonical NF-κB activation is attenuated by RIP1 through stabilization of TRAF2.
    Kim JY, Morgan M, Kim DG, Lee JY, Bai L, Lin Y, Liu ZG, Kim YS.
    J Cell Sci; 2011 Feb 15; 124(Pt 4):647-56. PubMed ID: 21266470
    [Abstract] [Full Text] [Related]

  • 3. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling.
    Kanno Y, Sakurai D, Hase H, Kojima H, Kobata T.
    J Recept Signal Transduct Res; 2010 Apr 15; 30(2):121-32. PubMed ID: 20184394
    [Abstract] [Full Text] [Related]

  • 4. Regulation and function of IKK and IKK-related kinases.
    Häcker H, Karin M.
    Sci STKE; 2006 Oct 17; 2006(357):re13. PubMed ID: 17047224
    [Abstract] [Full Text] [Related]

  • 5. Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.
    Razani B, Zarnegar B, Ytterberg AJ, Shiba T, Dempsey PW, Ware CF, Loo JA, Cheng G.
    Sci Signal; 2010 May 25; 3(123):ra41. PubMed ID: 20501937
    [Abstract] [Full Text] [Related]

  • 6. Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice.
    Yin L, Wu L, Wesche H, Arthur CD, White JM, Goeddel DV, Schreiber RD.
    Science; 2001 Mar 16; 291(5511):2162-5. PubMed ID: 11251123
    [Abstract] [Full Text] [Related]

  • 7. TNF receptor-associated factor 1 is a positive regulator of the NF-kappaB alternative pathway.
    Lavorgna A, De Filippi R, Formisano S, Leonardi A.
    Mol Immunol; 2009 Oct 16; 46(16):3278-82. PubMed ID: 19698991
    [Abstract] [Full Text] [Related]

  • 8. Positive and negative signaling components involved in TNFalpha-induced NF-kappaB activation.
    Li H, Lin X.
    Cytokine; 2008 Jan 16; 41(1):1-8. PubMed ID: 18068998
    [Abstract] [Full Text] [Related]

  • 9. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
    Hauer J, Püschner S, Ramakrishnan P, Simon U, Bongers M, Federle C, Engelmann H.
    Proc Natl Acad Sci U S A; 2005 Feb 22; 102(8):2874-9. PubMed ID: 15708970
    [Abstract] [Full Text] [Related]

  • 10. Methods to assess the activation of the alternative (noncanonical) NF-κB pathway by non-death TNF receptors.
    Remouchamps C, Dejardin E.
    Methods Mol Biol; 2015 Feb 22; 1280():103-19. PubMed ID: 25736746
    [Abstract] [Full Text] [Related]

  • 11. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
    Jackson-Bernitsas DG, Ichikawa H, Takada Y, Myers JN, Lin XL, Darnay BG, Chaturvedi MM, Aggarwal BB.
    Oncogene; 2007 Mar 01; 26(10):1385-97. PubMed ID: 16953224
    [Abstract] [Full Text] [Related]

  • 12. AWP1 binds to tumor necrosis factor receptor-associated factor 2 (TRAF2) and is involved in TRAF2-mediated nuclear factor-kappaB signaling.
    Chang EJ, Ha J, Kang SS, Lee ZH, Kim HH.
    Int J Biochem Cell Biol; 2011 Nov 01; 43(11):1612-20. PubMed ID: 21810480
    [Abstract] [Full Text] [Related]

  • 13. Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways.
    Pham LV, Fu L, Tamayo AT, Bueso-Ramos C, Drakos E, Vega F, Medeiros LJ, Ford RJ.
    Blood; 2011 Jan 06; 117(1):200-10. PubMed ID: 20889926
    [Abstract] [Full Text] [Related]

  • 14. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y, Ichikawa H, Pataer A, Swisher S, Aggarwal BB.
    Oncogene; 2007 Feb 22; 26(8):1201-12. PubMed ID: 16924232
    [Abstract] [Full Text] [Related]

  • 15. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.
    Vallabhapurapu S, Matsuzawa A, Zhang W, Tseng PH, Keats JJ, Wang H, Vignali DA, Bergsagel PL, Karin M.
    Nat Immunol; 2008 Dec 22; 9(12):1364-70. PubMed ID: 18997792
    [Abstract] [Full Text] [Related]

  • 16. Functional characterization of TNF-α in grass carp head kidney leukocytes: induction and involvement in the regulation of NF-κB signaling.
    Zhang A, Chen D, Wei H, Du L, Zhao T, Wang X, Zhou H.
    Fish Shellfish Immunol; 2012 Nov 22; 33(5):1123-32. PubMed ID: 22981915
    [Abstract] [Full Text] [Related]

  • 17. TNF receptor-associated factor-2 is involved in both IL-1 beta and TNF-alpha signaling cascades leading to NF-kappa B activation and IL-8 expression in human intestinal epithelial cells.
    Jobin C, Holt L, Bradham CA, Streetz K, Brenner DA, Sartor RB.
    J Immunol; 1999 Apr 15; 162(8):4447-54. PubMed ID: 10201981
    [Abstract] [Full Text] [Related]

  • 18. Activation-induced tumor necrosis factor receptor-associated factor 3 (Traf3) alternative splicing controls the noncanonical nuclear factor κB pathway and chemokine expression in human T cells.
    Michel M, Wilhelmi I, Schultz AS, Preussner M, Heyd F.
    J Biol Chem; 2014 May 09; 289(19):13651-60. PubMed ID: 24671418
    [Abstract] [Full Text] [Related]

  • 19. TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling.
    Kim YS, Nedospasov SA, Liu ZG.
    Mol Cell Biol; 2005 Mar 09; 25(6):2130-7. PubMed ID: 15743811
    [Abstract] [Full Text] [Related]

  • 20. Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.
    Hildebrand JM, Yi Z, Buchta CM, Poovassery J, Stunz LL, Bishop GA.
    Immunol Rev; 2011 Nov 09; 244(1):55-74. PubMed ID: 22017431
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.